Efficacy and Safety of Madalena Association in the Treatment of Type II Diabetes Mellitus
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 270 participants.
Also called NCT04670666
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 270 participants
- Sponsor
- EMS
- Registry
-
NCT04670666
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Brazil
- Registry status
- Recruiting
Technical summary
Registry record NCT04670666. Randomized; double masking; primary purpose treatment. Start 2024-11-18 (actual); primary completion 2026-07 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of Madalena Association in the Treatment of Type II Diabetes Mellitus
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- MADALENA ASSOCIATION
- Intervention (Drug)
- METFORMIN
- Intervention (Drug)
- EMPAGLIFLOZIN + LINAGLIPTIN
- Intervention (Other)
- MADALENA ASSOCIATION PLACEBO
- Intervention (Other)
- METFORMIN PLACEBO
- Intervention (Other)
- EMPAGLIFLOZIN + LINAGLIPTIN PLACEBO
- Lead sponsor
- EMS
Record details
- Record id
cardio:ct-nct04670666- Content hash
f968c1ed6c110085b8525634bfc9d82ffb6cf8a214f1c0ddb80cb130a7d5225a